Urgent Opposition Raised Against Proposed Policy Change on PRIALT Coverage
PubComNonGov
Copyright © Targeted News Service, 2025
Copyright © Targeted News Service, 2025
2025-08-23
Carter Struck
WASHINGTON, Aug. 23 -- Hawthorne Oncology Pain Experts has issued a public comment letter to the Centers for Medicare & Medicaid Services, expressing strong opposition to a proposed change in the Calendar Year 2026 Hospital Outpatient Prospective Payment System. The change threatens to eliminate Medicare Part B coverage for certain medications, including PRIALT (ziconotide), the only FDA-approved non-opioid intrathecal therapy for chronic severe pain, from manufacturers that do not participate i . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, Aug. 23 -- Hawthorne Oncology Pain Experts has issued a public comment letter to the Centers for Medicare & Medicaid Services, expressing strong opposition to a proposed change in the Calendar Year 2026 Hospital Outpatient Prospective Payment System. The change threatens to eliminate Medicare Part B coverage for certain medications, including PRIALT (ziconotide), the only FDA-approved non-opioid intrathecal therapy for chronic severe pain, from manufacturers that do not participate i . . .
To gain access to full content fill out the form below.
Information Request Form
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
